ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $395,000 | +163.3% | 20,165 | +114.4% | 0.16% | +150.8% |
| Q3 2022 | $150,000 | -100.0% | 9,404 | -91.5% | 0.06% | -89.6% |
| Q2 2022 | $1,516,000,000 | +180.2% | 110,145 | +222.7% | 0.63% | +193.9% |
| Q1 2022 | $541,000,000 | -29.8% | 34,136 | -3.3% | 0.21% | -31.3% |
| Q4 2021 | $771,000,000 | – | 35,302 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |